Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis

Cancer Epidemiology

Volumn 36, Issue 1, 2012, Pages

  Wang, Long Gang ^a   Gu, Jin ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Colorectal cancer; Early diagnosis; Liver metastasis; MicroRNA; Serum

Indexed keywords

BIOLOGICAL MARKER; CARCINOEMBRYONIC ANTIGEN; MICRORNA; MICRORNA 29A; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER PATIENT; CANCER SURVIVAL; COLORECTAL CANCER; COLORECTAL LIVER METASTASIS; EARLY DIAGNOSIS; FEMALE; HUMAN; HUMAN TISSUE; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM METASTASIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84855859459     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2011.05.002     Document Type: Article

References (24)

1. Kumar V., Abbas A.K., Fausto N. Robbins and Cotran pathologic basis of disease 2005, Elsevier Saunders, Philadelphia. 7th ed.
2. Rothbarth J., van de Velde C.J. Treatment of liver metastases of colorectal cancer. Ann Oncol 2005, 16(Suppl 2):ii144-ii149.
3. Paschos K.A., Bird N. Current diagnostic and therapeutic approaches for colorectal cancer liver metastasis. Hippokratia 2008, 12:132-138.
4. Metcalfe M.S., Bridgewater F.H., Mullin E.J., Maddern G.J. Useless and dangerous-fine needle aspiration of hepatic colorectal metastases. BMJ 2004, 328:507-508.
5. Bipat S., van Leeuwen M.S., Ijzermans J.N., Comans E.F., Planting A.S., Bossuyt P.M., et al. Evidence-base guideline on management of colorectal liver metastases in the Netherlands. Neth J Med 2007, 65:5-14.
6. Meister G. miRNAs get an early start on translational silencing. Cell 2007, 131:25-28.
7. Calin G.A., Liu C.G., Sevignani C., Ferracin M., Felli N., Dumitru C.D., et al. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci USA 2004, 101:11755-11760.
8. Lawrie C.H., Gal S., Dunlop H.M., Pushkaran B., Liggins A.P., Pulford K., et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 2008, 141:672-675.
9. Chen X., Ba Y., Ma L., Cai X., Yin Y., Wang K., et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008, 18:997-1006.
10. Mitchell P.S., Parkin R.K., Kroh E.M., Fritz B.R., Wyman S.K., Pogosova-Agadjanyan E.L., et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008, 105:10513-10518.
11. Taylor D.D., Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 2008, 110:13-21.
12. Gilad S., Meiri E., Yogev Y., Benjamin S., Lebanony D., Yerushalmi N., et al. Serum microRNAs are promising novel biomarkers. PLoS ONE 2008, 3:e3148.
13. Ho A.S., Huang X., Cao H., Christman-Skieller C., Bennewith K., Le Q.T., et al. Circulating miR-210 as a novel hypoxia marker in pancreatic cancer. Transl Oncol 2010, 3:109-113.
14. Ji X., Takahashi R., Hiura Y., Hirokawa G., Fukushima Y., Iwai N. Plasma miR-208 as a biomarker of myocardial injury. Clin Chem 2009, 55:1944-1949.
15. Resnick K.E., Alder H., Hagan J.P., Richardson D.L., Croce C.M., Cohn D.E. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol 2009, 112:55-59.
16. Wang K., Zhang S., Marzolf B., Troisch P., Brightman A., Hu Z., et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci USA 2009, 106:4402-4407.
17. Huang Z., Huang D., Ni S., Peng Z., Sheng W., Du X. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 2010, 127:118-126.
18. Ng E.K., Chong W.W., Jin H., Lam E.K., Shin V.Y., Yu J., et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 2009, 58:1375-1381.
19. Schmittgen T.D., Livak K.J. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008, 3:1101-1108.
20. Wong T.S., Liu X.B., Wong B.Y., Ng R.W., Yuen A.P., Wei W.I. Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res 2008, 14:2588-2592.
21. Ottmar M.D., Gonda R.L., Leithauser K.J., Gutierrez O.H. Liver function tests in patients with computed tomography demonstrated hepatic metastases. Gastrointest Radiol 1989, 14:55-58.
22. Mielczarek M., Chrzanowska A., Scibior D., Skwarek A., Ashamiss F., Lewandowska K., et al. Arginase as a useful factor for the diagnosis of colorectal cancer liver metastases. Int J Biol Markers 2006, 21:40-44.
23. Fabbri M., Garzon R., Cimmino A., Liu Z., Zanesi N., Callegari E., et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci USA 2007, 104:15805-15810.
24. Gebeshuber C.A., Zatloukal K., Martinez J. miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. EMBO Rep 2009, 10:400-405.